A simple example is Bisantrene synergises with Doxorubicin and no other anthracyclines.
Another simple example is Bisantrene synergises with Doxorubicin only in Breast, Lung, and Ovarian cancer and AML.
Bisantrene demonstrating CPACS in Breast cancer alone would still drive insane value from here, but it would not be maximised for the potential.
A simple example is Bisantrene synergises with Doxorubicin and...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.62 |
Change
-0.060(3.57%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.68 | $1.61 | $48.57K | 29.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1125 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 100 | 1 |
View Market Depth
| Last trade - 12.32pm 04/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |